pteridines has been researched along with Burkitt Lymphoma in 1 studies
Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, E | 1 |
| Pei, R | 1 |
1 other study available for pteridines and Burkitt Lymphoma
| Article | Year |
|---|---|
BI6727, a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells.
Topics: Adolescent; Adult; Aged; Burkitt Lymphoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; F-B | 2020 |